{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-064067","form_type":"8-K","ticker":"DCGO","cik":"0001822359","company_name":"DocGo Inc.","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.453076+00:00","generated_at":"2026-06-12T04:46:20.303674+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"DocGo Q2 revenue $125.5M, raises FY2023 revenue guidance to $540-550M","bullets":["Total revenue $125.5M, up 15% sequentially; net income $1.3M vs net loss $3.9M in Q1.","Excluding mass COVID-testing (under $1M), core revenue grew 53% YoY.","FY2023 revenue guidance raised to $540-550M, Adjusted EBITDA guidance to $48-53M.","Backlog increased to $325M from $205M as of May 8, driven by Mobile Health wins.","Cash $123.8M, no material debt, $90M undrawn credit line."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-064067","json":"https://secwatch.observer/filing/0001213900-23-064067.json","markdown":"https://secwatch.observer/filing/0001213900-23-064067.md","text":"https://secwatch.observer/filing/0001213900-23-064067.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023064067/0001213900-23-064067-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023064067/ea182961-8k_docgo.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T04:46:20.303674+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8b398de66f2f380446c4e623bcf866b37bdca03b","claim":"DocGo Inc. reported the quarter ended June 30, 2023 results: revenue $125.5 million, net income $1.3 million. Guidance raised.","evidence_excerpt":"services today announced financial and operating results for the quarter ended June 30, 2023. Q2 2023 Financial Highlights ● Total revenue for the second quarter of 2023 was $125.5 million, up from $113.0 million in the first quarter of 2023 and $109.5 million in the second quarter of 2022. Mass COVID-testing revenues during each of the first two quarters of 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822359/000121390023064067/0001213900-23-064067-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"$125.5 million"},{"label":"Net income","value":"$1.3 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}